首页 | 本学科首页   官方微博 | 高级检索  
检索        

眼部新生血管与抗血管内皮生长因子治疗
引用本文:刘正,王业青,张晓梅.眼部新生血管与抗血管内皮生长因子治疗[J].国际眼科杂志,2007,7(3):779-781.
作者姓名:刘正  王业青  张晓梅
作者单位:150001,中国黑龙江省哈尔滨市,哈尔滨医科大学第一临床医学院附属眼科医院
摘    要:眼部新生血管性病变是致盲的主要原因之一,可见于多种眼底疾病,其确切的发病机制尚不完全清楚.大量的研究证据表明血管内皮生长因子(VEGF)是新生血管形成的关键调控因子.本文对VEGF的特性、VEGF在眼部新生血管形成中的作用和抗VEGF治疗进行综述.

关 键 词:新生血管  血管内皮生长因子  治疗  眼部新生血管  血管内皮生长因子  治疗  neovascularization  ocular  treatment  作用  特性  调控因子  新生血管形成  VEGF  证据  研究  完全  发病机制  眼底疾病  致盲  血管性病
修稿时间:2007-03-092007-05-28

Anti-vascular endothelial growth factor treatment for ocular neovascularization
Zheng Liu,Ye-Qing Wang,Xiao-Mei Zhang.Anti-vascular endothelial growth factor treatment for ocular neovascularization[J].International Journal of Ophthalmology,2007,7(3):779-781.
Authors:Zheng Liu  Ye-Qing Wang  Xiao-Mei Zhang
Institution:Department of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Abstract:Ocular neovascularization is the primary cause of blindness in a wide range of ocular diseases. The exact mechanism underlying the pathogenesis of ocular neovascularization is not yet well understood. There is extensive evidence that vascular endothelial growth factor(VEGF) is a major regulator of neovascularization. The present paper focuses on VEGF and its role in ocular neovascularization and current anti-VEGF treatment.
Keywords:neovascularization  vascular endothelial growth factor  treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号